Neurovascular Transduction During Exercise in Chronic Kidney Disease

  • STATUS
    Recruiting
  • End date
    Sep 1, 2022
  • participants needed
    150
  • sponsor
    Emory University
Updated on 26 January 2021
renal function
epinephrine
nephropathy
folic acid
folate

Summary

The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and to explore what causes an increase in blood pressure during exercise (i.e. increased adrenaline levels, or decreased ability of blood vessels to dilate). This study will also test whether or not regular exercise on a bicycle and/or treatment with 6R-BH4 (Kuvan) pills, or histidine and beta-alanine supplementation improves these measures during exercise. 6R-BH4 is currently FDA-approved for use in patients with certain forms of a disease called phenylketonuria, but it is not currently FDA approved for blood pressure or exercise capacity in people with CKD.

Description

The major problem addressed in this study is to understand mechanisms underlying poor exercise capacity in patients with chronic kidney disease (CKD). Prior research has found that CKD patients have an exaggerated increase in blood pressure during certain forms of exercise that could contribute to exercise dysfunction as well as cardiovascular disease. This study will test the mechanisms underlying this exaggerated blood pressure response, as well as the potential benefits of simple measures such as exercise training on a stationary bicycle, and treatment with 6R-BH4, a drug that is currently FDA-approved for the treatment of phenylketonuria, but has been shown to have beneficial effects on vascular health in patients with kidney disease. This study will also examine the effects of exercise with histidine and beta-alanine supplementation. Histidine and beta-alanine are two over-the-counter supplements commonly used to enhance sports performance in athletes.

Prior to the intervention portion of this study, the researchers will measure how much the vein constricts in response to adrenaline in CKD patients versus controls. The study will also measure muscle pH, and muscle oxygenation during exercise in CKD patients and controls.

The intervention portion of the study will test whether aerobic exercise training with and without 6R-BH4, or with and without histidine and beta-alanine supplementation might help muscle pH and adrenaline levels, vascular reactivity, muscle oxygenation, and the exaggerated blood pressure response during exercise in CKD patients. Participants will be randomized using a 2x2 factorial design to exercise training (ET) with 6R-BH4, ET with placebo, stretching (control condition to exercise) with 6R-BH4, and stretching with placebo. Participants will undergo exercise training on a stationary bicycle, or stretching exercises, 3 times per week for 6-14 weeks (depending on availability of the participant).

Details
Condition chronic renal insufficiency
Treatment Placebo, exercise training, Folic acid, 6R-BH4, Stretching, 6R-BH4 placebo, Histidine and beta-alanine supplementation, Histidine and beta-alanine placebo
Clinical Study IdentifierNCT02947750
SponsorEmory University
Last Modified on26 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Stage III or IV Chronic Kidney Disease, defined as reduction in estimated glomerular filtration rate (eGFR) to 15-59 cc/minute as calculated by the modified Modification of Diet in Renal Disease (MDRD) Study equation or the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
Stable renal function, with no greater than a 30% reduction in eGFR over the prior 3 months
Does not exercise regularly (defined as exercising less than 20 minutes twice per week)
Willing and able to cooperate with the study protocol
Inclusion Criteria for Control Study Participants
Does not exercise regularly (defined as exercising less than 20 minutes twice per week)
Willing and able to cooperate with the study protocol

Exclusion Criteria

severe CKD (eGFR<15 cc/minute)
ongoing drug or alcohol abuse
diabetic neuropathy
any serious systemic disease that might influence survival
severe anemia with hgb level <9 g/dL
clinical evidence of congestive heart failure or ejection fraction below 35%
symptomatic heart disease determined by prior electrocardiogram, stress test, and/or history
treatment with central alpha agonists (clonidine)
uncontrolled hypertension with BP greater than 170/100 mm Hg
low blood pressure with BP less than 100/50
pregnancy or plans to become pregnant
current treatment with monoamine oxidase (MAO) inhibitors
inability to exercise on a stationary bicycle
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note